Pacific Biosciences of California

PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. We provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. Our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. With a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Menlo Park, US
Size (employees)
438 (est)+12%
Pacific Biosciences of California was founded in 2004 and is headquartered in Menlo Park, US

Pacific Biosciences of California Office Locations

Pacific Biosciences of California has an office in Menlo Park
Menlo Park, US (HQ)
1380 Willow Rd

Pacific Biosciences of California Data and Metrics

Pacific Biosciences of California Financial Metrics

Pacific Biosciences of California's revenue was reported to be $90.7 m in FY, 2016 which is a 2% decrease from the previous period.

Revenue (FY, 2016)

90.7 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

44.2 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(74.4 m)

EBIT (FY, 2016)

(71.2 m)

Market capitalization (26-Jun-2017)

338.7 m

Closing share price (26-Jun-2017)


Cash (31-Dec-2016)

16.8 m


354.1 m
Pacific Biosciences of California's current market capitalization is $338.7 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


28.2 m60.6 m92.8 m90.7 m

Revenue growth, %


Cost of goods sold

21.8 m37.2 m39.3 m46.6 m

Gross profit

6.4 m23.4 m53.5 m44.2 m

Gross profit Margin, %


Operating expense total

84 m86.3 m82.6 m115.4 m


(77.5 m)(62.9 m)(29.1 m)(71.2 m)

EBIT margin, %


Interest expense

2.5 m2.8 m2.9 m3.2 m

Net Income

(79.3 m)(66.2 m)(31.7 m)(74.4 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016


26.4 m36.4 m33.6 m16.8 m

Accounts Receivable

2.7 m3.4 m5.2 m11.4 m


1.1 m1.7 m12.1 m10 m

Current Assets

126.5 m117.8 m110.5 m109 m


9.2 m6.6 m8.5 m14.6 m

Total Assets

136.2 m124.5 m131.1 m137.9 m

Accounts Payable

1.7 m5.6 m4.7 m8.4 m

Total Debt

28.2 m29.9 m32.2 m

Current Liabilities

22.6 m31.5 m38.2 m33.8 m

Additional Paid-in Capital

684.4 m736.3 m786.6 m872.1 m

Retained Earnings

(615.3 m)(681.5 m)(713.2 m)(787.5 m)

Total Equity

69.2 m54.9 m73.5 m84.7 m

Debt to Equity Ratio

0.5 x0.4 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x

Financial Leverage

2 x2.3 x1.8 x1.6 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(79.3 m)(66.2 m)(31.7 m)(74.4 m)

Depreciation and Amortization

5.6 m4.2 m3.7 m3.9 m

Accounts Receivable

76 k(660 k)(1.7 m)(6.2 m)


(60 k)(1.3 m)(2.5 m)(6.2 m)

Accounts Payable

(1.3 m)3.9 m(716 k)3.4 m

Cash From Operating Activities

(29.8 m)(51.5 m)(47.9 m)(67.9 m)

Purchases of PP&E

(909 k)(1.6 m)(3 m)(8.2 m)

Cash From Investing Activities

(33.1 m)19.6 m8.6 m(14.9 m)

Cash From Financing Activities

42.8 m42 m36.5 m65.9 m

Interest Paid

1.2 m1.8 m1.8 m1.8 m
Y, 2016


-5 x


-5.2 x


0.4 x


0.2 x

Financial Leverage

1.6 x

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (US)


Patents Pending


Patents (foreign)


Pacific Biosciences of California Market Value History

Pacific Biosciences of California Revenue Breakdown

Pacific Biosciences of California Median Salaries

Source: 25 public H-1B filings from Pacific Biosciences of California

Pacific Biosciences of California Online and Social Media Presence

Pacific Biosciences of California Company Life and Culture

You may also be interested in